secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-09-04T10:01:29+00:00
Accession:  0001628280-26-060600
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences issues $2M convertible notes, secures $2.5M equity commitment from Celadon affiliate
--------------------------------------------------------------------------------

- Issued $2.0M aggregate principal Senior Secured Convertible Notes to NSG BioInnovation Fund on Sept 3, 2026.
- Notes mature Nov 23, 2026, repayable at 200% of principal; 12% default interest rate applies upon event of default.
- Entered equity commitment letter with Celadon affiliate (CPIF II-9 Limited) to purchase $2.5M common stock at Nasdaq Minimum Price.
- Shares to be purchased at closing of merger with Celadon affiliate; contingent value right up to $60M cash tied to SENTI-202 milestones.
- Merger and CVR subject to stockholder approval; definitive proxy statement to be mailed after filing with SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/0001628280-26-060600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/snti-20260903.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-060600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer